SU006668 in Treating Patients With Advanced Solid Tumors

ABSTRACT: RATIONALE: Drugs such as SU006668 may stop the growth of solid tumors by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of SU006668 in treating patients who have advanced solid tumors.

DISEASE(S): Lung Cancer,Multiple Myeloma And Plasma Cell Neoplasm,Colorectal Cancer,Pancreatic Cancer,Breast Neoplasms,Breast Cancer,Lung Neoplasms,Prostatic Neoplasms,Gastric Cancer,Prostate Cancer,Plasmacytoma,Kidney Cancer,Pancreatic Neoplasms,Stomach Neoplasms,Neoplasms, Plasma Cell,Multiple Myeloma

PROVIDER: 2006700 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR